Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first

Fig. 1

Whole body PET-CT following initiation of immunotherapy. Maximum intensity projection (a) and axial fused images (b-d) demonstrates symmetric increased metabolic activity at the bilateral supraspinatus (solid arrows), gluteus medius/minimus (dashed arrows), and semimembranosus (arrowheads) tendon insertions. There is also focally increased metabolic activity at the right elbow (asterisk)

Back to article page